Filing metadata

Accession number
0001209191-22-051817
Form type
Form 3
Filer
Lyell Immunopharma, Inc.
CIK
CIK 1806952
Filed
Oct 03, 2022
Reporting period
Sep 28, 2022
Description
Initial ownership

Explore SEC Filings Hub